CHARACTERIZATION/MODULATION OF CYTOKINE RESPONSES IN FIV
CHARACTERIZATION/MODULATION OF CYTOKINE RESPONSES IN FIV
批准号:
6373563
负责人:
Gregg A Dean
金额:
$8.11万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 2003-02-28
关键词:
Listeria antibody cats cellular immunity cytokine feline immunodeficiency virus flow cytometry immunocytochemistry in situ hybridization interferon gamma interleukin 10 interleukin 12 interleukin 2 interleukin 4 messenger RNA polymerase chain reaction protein biosynthesis tumor necrosis factor alpha vector vaccine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this proposal is to comprehensively characterize
cytokine mRNA and protein expression in the lymphoid tissues of
FIV-infected cats and attempt to modulate the cytokine response
with anti-cytokine antibodies and recombinant Listeria
monocytogenes. Hypothesis: Inappropriate cytokine production
contributes to the ineffective immune response to FIV, the patho-
genesis of FIV, and the susceptibility of FIV infected cats to
opportunistic infections. Modulation of cytokines may be useful to
study the efficacy of therapeutic interventions and vaccine
strategies, as well as the pathogenesis of FIV. Specific Aim 1: to
determine the effect of FIV infection on cytokine mRNA and
protein production in tissues of cats, multiple lymphoid
compartments will be evaluated by QC-RT-PCR to quantify tissue
production of cytokine mRNA, by in situ hybridization to localize
mRNA within the tissue structure, and by immunocytochemistry,
ELIspot, and flow cytometry to determine cytokine protein
production within specific cell phenotypes. Specific Aim 2: to
determine the significance of IL2, IL4, IL10, IL12, TNF-alpha and
IFN-gamma in the immunopathogenesis of FIV, anti-IL2, anti-IL4,
anti-IL10, anti-IL12p40, anti-TNF-alpha or anti-IFN-gamma
monoclonal and polyclonal antibodies will be administered to
acutely FIV infected cats. The effects of cytokine inhibition on
viral replication, immune response, and disease progression will be
determined. Specific Aim 3: To determine if a strong cell-mediated
immunity to FIV is protective, SPF cats will be vaccinated with live
recombinant biological vaccine vector; FIVenv- and/or FIVgag-
expressing Listeria monocytogenes. Cats will then be challenged
with homologous and heterologous FIV and the immune response
and cytokine profile associated with either protective or non-
protective immunity will be evaluated. Significance: Lentivirus-
associated immunodeficiency is an expanding global problem
affecting humans and cats, however the immunopathogenesis is
incompletely understood and current therapies are limited.
Understanding the role of the cytokines in the pathogenesis,
therapy, and vaccination in FIV infection will have direct
implications for HIV infection.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
对致病性单核细胞增生李斯特菌的预先存在的免疫力不会阻止新型重组单核细胞增生李斯特菌疫苗诱导对猫免疫缺陷病毒的免疫反应。
DOI:
10.1016/j.vaccine.2004.09.033
发表时间:
2005
期刊:
Vaccine.
影响因子:
--
作者:
[Stevens,Rosemary, Lavoy,Alora, Nordone,Shila, Burkhard,Maryjo, Dean,GreggA]
通讯作者:
Dean,GreggA
Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus.
用重组单核细胞增生李斯特氏菌口服免疫可控制猫免疫缺陷病毒阴道攻击后的病毒载量。
DOI:
10.1128/jvi.78.15.8210-8218.2004
发表时间:
2004
期刊:
Journal of virology
影响因子:
5.4
作者:
[Stevens,Rosemary, Howard,KristinaE, Nordone,Sushila, Burkhard,MaryJo, Dean,GreggA]
通讯作者:
Dean,GreggA
MARC at Colorado State University
-
批准号:10411535
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2022
-
负责人:Gregg A Dean
-
依托单位:
MARC at Colorado State University
-
批准号:10618902
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2022
-
负责人:Gregg A Dean
-
依托单位:
CSU Infectious Disease Research and Response Training Program
-
批准号:10657788
-
项目类别:
-
资助金额:$46.52万
-
财政年份:2021
-
负责人:Gregg A Dean
-
依托单位:
CSU Infectious Disease Research and Response Training Program
-
批准号:10490359
-
项目类别:
-
资助金额:$46.17万
-
财政年份:2021
-
负责人:Gregg A Dean
-
依托单位:
CSU Infectious Disease Research and Response Training Program
-
批准号:10268828
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2021
-
负责人:Gregg A Dean
-
依托单位:
Oral Induction of Mucosal and Systemic Antibodies Against HIV-1 gp41 MPER
-
批准号:8892070
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2014
-
负责人:Gregg A Dean
-
依托单位:
Oral Induction of Mucosal and Systemic Antibodies Against HIV-1 gp41 MPER
-
批准号:8790302
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2014
-
负责人:Gregg A Dean
-
依托单位:
International Feline Retrovirus Research Symposium
-
批准号:7927868
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2010
-
负责人:Gregg A Dean
-
依托单位:
Recombinant Lactobacillus as an Oral Mucosal Vaccine Against HIV-1
-
批准号:7932516
-
项目类别:
-
资助金额:$20.74万
-
财政年份:2009
-
负责人:Gregg A Dean
-
依托单位:
Comparative Medicine and Translational Research Training Program
-
批准号:7667328
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Optimizing Immunogenicity of Lactobacillus as a Mucosal Vaccine Against HIV-1
-
批准号:7494877
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Comparative Medicine and Translational Research Training Program
-
批准号:7900894
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Recombinant Lactobacillus as an Oral Mucosal Vaccine Against HIV-1
-
批准号:8208234
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Recombinant Lactobacillus as an Oral Mucosal Vaccine Against HIV-1
-
批准号:7588810
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Recombinant Lactobacillus as an Oral Mucosal Vaccine Against HIV-1
-
批准号:7750586
-
项目类别:
-
资助金额:$34.3万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Recombinant Lactobacillus as an Oral Mucosal Vaccine Against HIV-1
-
批准号:7485532
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Recombinant Lactobacillus as an Oral Mucosal Vaccine Against HIV-1
-
批准号:8412045
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Comparative Medicine and Translational Research Training Program
-
批准号:7502342
-
项目类别:
-
资助金额:$12.9万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
Optimizing Immunogenicity of Lactobacillus as a Mucosal Vaccine Against HIV-1
-
批准号:7563270
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2008
-
负责人:Gregg A Dean
-
依托单位:
In vivo significance of T-reg cells during FIV infection
-
批准号:7005510
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2005
-
负责人:Gregg A Dean
-
依托单位:
海外基金